Apellis Pharmaceuticals Correlations

APLS Stock

USD 31.91 1.14 3.70%

The current 90-days correlation between Apellis Pharmaceuticals and Eliem Therapeutics is 0.06 (i.e., Significant diversification). The correlation of Apellis Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Apellis Pharmaceuticals Correlation With Market

Average diversification

The correlation between Apellis Pharmaceuticals and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apellis Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Apellis Stock please use our How to Invest in Apellis Pharmaceuticals guide.

Moving together with Apellis Stock

0.81	VALN	Valneva SE ADR	Pair Corr
0.7	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.62	IPSC	Century Therapeutics	Pair Corr
0.83	NKTX	Nkarta Inc	Pair Corr
0.65	AGL	agilon health Buyout Trend	Pair Corr
0.85	BACK	IMAC Holdings	Pair Corr
0.74	CYRX	Cryoport	Pair Corr
0.71	VFSWW	VinFast Auto	Pair Corr
0.75	EC	Ecopetrol SA ADR	Pair Corr

Moving against Apellis Stock

0.78	KZR	Kezar Life Sciences	Pair Corr
0.63	MLYS	Mineralys Therapeutics,	Pair Corr
0.91	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr
0.91	HD	Home Depot	Pair Corr
0.86	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.8	INTC	Intel Fiscal Year End 23rd of January 2025	Pair Corr
0.76	HPQ	HP Inc	Pair Corr
0.76	T	ATT Inc Sell-off Trend	Pair Corr
0.67	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr
0.65	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.64	GE	GE Aerospace Fiscal Year End 28th of January 2025	Pair Corr
0.62	MCD	McDonalds Fiscal Year End 3rd of February 2025	Pair Corr
0.6	DD	Dupont De Nemours Fiscal Year End 4th of February 2025	Pair Corr
0.53	BAC	Bank of America Aggressive Push	Pair Corr
0.45	KB	KB Financial Group	Pair Corr
0.41	VFS	VinFast Auto Earnings Call Tomorrow	Pair Corr

Related Correlations Analysis

	ELYM	HCWB	SCPH	MIST	MCRB	LUMO
ELYM		-0.01	0.87	-0.52	0.83	-0.66	ELYM
HCWB	-0.01		-0.17	0.1	0.11	0.01	HCWB
SCPH	0.87	-0.17		-0.52	0.72	-0.57	SCPH
MIST	-0.52	0.1	-0.52		-0.42	0.49	MIST
MCRB	0.83	0.11	0.72	-0.42		-0.6	MCRB
LUMO	-0.66	0.01	-0.57	0.49	-0.6		LUMO
	ELYM	HCWB	SCPH	MIST	MCRB	LUMO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SCPH	+ 0.87	ELYM
MCRB	+ 0.83	ELYM
MCRB	+ 0.72	SCPH
LUMO	+ 0.49	MIST
MCRB	+ 0.11	HCWB
MIST	+ 0.1	HCWB

High negative correlations

LUMO	- 0.66	ELYM
LUMO	- 0.6	MCRB
LUMO	- 0.57	SCPH
MIST	- 0.52	SCPH
MIST	- 0.52	ELYM
MCRB	- 0.42	MIST

Risk-Adjusted Indicators

There is a big difference between Apellis Stock performing well and Apellis Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Apellis Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ELYM	3.92	(0.95)	0.00	(5.36)	0.00	0.00	6.21	(9.35)	34.87
HCWB	13.22	4.45	0.42	(1.48)	7.39	(21.79)	22.00	(13.64)	352.85
SCPH	2.68	(0.82)	0.00	(0.32)	0.00	0.00	4.30	(7.09)	20.70
MIST	1.92	0.21	0.13	0.25	1.60	(2.86)	7.19	(2.11)	18.66
MCRB	4.68	0.01	(0.02)	0.25	5.68	(5.36)	10.00	(9.78)	28.84
LUMO	2.77	0.61	0.15	(3.14)	2.60	(3.21)	6.35	(5.19)	26.13

Apellis Pharmaceuticals Corporate Management

James CPA	Corporate VP	Profile
Cedric MD	President, CoFounder	Profile
Adam Townsend	Chief Commercial Officer	Profile
Karen Lewis	Chief Officer	Profile
Nur Nicholson	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC